Title: Clinico-Pathological Study of Carcinoma Stomach over a Period of one year in a Tertiary Care Centre
Authors: Dr Kodanda Ramu Ulala, Dr Sekuboyina Kiran Datta, Dr Konkena Janardhana Rao, Dr Nadiminti Jaya Kavya
DOI: https://dx.doi.org/10.18535/jmscr/v7i5.134
Abstract
Background: Carcinoma stomach is the 5th most diagnosed cancer and 3rd leading cause of death from cancer worldwide. Most tumors are diagnosed within 4th to 7th decades of life. Patients generally present in advanced stage, when early gastric cancer is identified survival rates are comparatively greater. The present study aims to evaluate the various modes of presentation of carcinoma stomach, treatment strategies and the associated morbidity and mortality for a better outcome.
Materials and Methods: A Retrospective study was conducted on 25 patients of carcinoma stomach in the Department of General Surgery, Andhra medical college, King George Hospital, Visakhapatnam from January 2017 to December 2017. Patients presenting with symptoms suggestive of gastric cancer were admitted, examined, investigated using CT, upper GI endoscopy and operated during this period. Factors studied were, epidemiology, mode of presentation, endoscopy findings, CT findings, treatment, associated morbidity and mortality.
Results: Of the 25 patients studied 18 were male and 7 were female, most common age group being 50-60 years. Anemia, vomiting, pain abdomen were the most common modes of presentation. Most common site was the pylorus and antrum. 32% of patients underwent curative resection and the rest had palliative treatment. Most common histopathology was infiltrating intestinal type. Mortality rate in our study was 12%.
Conclusion: Carcinoma stomach was seen most commonly after 5th decade of life. Unfortunately, most cases were diagnosed in advanced stage. Symptoms like weight loss, vague abdominal pain should alert the possibility of gastric cancer. Increasing the awareness regarding etiology and varied clinical presentation is needed for early detection. Early diagnosis through prompt screening helps in reduction of mortality and morbidity.
Keywords: Ca stomach, upper GI endoscopy, diffuse type, infiltrating type.
References
- Byrne JP, Mathers JM, Parry JM, Attwood SE, Bancewicz J, Woodman CB. Site distribution of oesophagogastric cancer. J Clin Pathol2002; 55:191-4.
- Cervantes DT, Fischbach LA. Gastric cardia adenocarcinoma in Taiwanese men: positive associations due to selection bias. World J Gastroenterol2010; 16:1553-4.
- Hsu CC, Chen JJ, Changchien CS. Endoscopic features of metastatic tumours in the upper gastrointestinal tract. Endoscopy 1996; 28:249-53.
- Sun W, Haller DG. Recent advances in the treatment of gastric cancer. Drugs 2001; 61:1545-51.
- Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362:305-15.
- Green D, Ponce de Leon S, Leon-Rodriguez E, Sosa-Sanchez R. Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival. Am J ClinOncol2002; 25:84-9.
- Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population based study. Eur J Cancer 2000; 36:390-6.
- Kim ST, Kang WK, Kang JH, Park KW, Lee J, Lee SH, et al. Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer. Br J Cancer 2005; 92:1850-4.
- Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240:28-37.
- Role of surgery in the treatment of gastric lymphoma. Ann Surg2004; 240:28-37.